• Bunge Global has recently been flagged for slower revenue growth than many consumer staples peers, falling earnings per share despite higher sales, and a drawdown in cash reserves, raising questions about the strength of its operations and balance sheet.
• An important concern now is the possibility that Bunge may need to raise fresh capital, which could dilute existing shareholders and complicate how investors assess its longer-term attractiveness.
• With worries about potential dilution now in focus, we’ll examine how this development may reshape Bunge Global’s previously optimistic investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 53 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Bunge Global Investment Narrative Recap

To own Bunge Global, you need to believe its integrated agribusiness model and the Viterra merger can still translate into resilient cash generation despite near term volatility. The latest signs of slower revenue growth, weaker earnings per share and thinner cash reserves matter because they sharpen the immediate risk that funding heavy capex and integration could require fresh capital, which now looks like the key short term overhang for the story.

The most relevant recent development here is Bunge’s Q1 2026 result, where sales rose to US$21,861 million but net income fell to US$68 million and EPS dropped to US$0.35. Taken with prior quarters, that pattern of higher sales but lower profitability and a draw on cash highlights how much execution and balance sheet discipline now matter to whether the Viterra integration and ongoing plant expansions can become the positive catalyst many shareholders are counting on.

Yet behind that, there is a separate risk around potential shareholder dilution that investors should be aware of if Bunge’s cash needs keep rising and ...

Bunge Global's narrative projects $100.1 billion revenue and $3.8 billion earnings by 2029. This implies 7.5% yearly revenue growth and about a $3.1 billion earnings increase from $686.0 million today.

Uncover how Bunge Global's forecasts yield a $142.00 fair value, a 19% upside to its current price.

Exploring Other Perspectives

Before this setback, the most optimistic analysts were assuming Bunge could lift earnings to about US$3.8 billion by 2029, which is a far more upbeat view than the more cautious concerns around rising interest costs and integration complexity that the latest results now bring into sharper focus.

Explore 3 other fair value estimates on Bunge Global - why the stock might be worth just $142.00!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Bunge Global research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Bunge Global research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Bunge Global's overall financial health at a glance.

Seeking Other Investments?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Find 46 companies with promising cash flow potential yet trading below their fair value.
• We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.